Effects of Infantile Hypophosphatasia on Human Dental Tissue.
ALPL
Enzyme replacement therapy
HPP
TNSALP
Tooth
Journal
Calcified tissue international
ISSN: 1432-0827
Titre abrégé: Calcif Tissue Int
Pays: United States
ID NLM: 7905481
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
25
08
2022
accepted:
02
11
2022
pubmed:
23
11
2022
medline:
3
3
2023
entrez:
22
11
2022
Statut:
ppublish
Résumé
Hypophosphatasia (HPP) is an inherited, systemic disorder, caused by loss-of-function variants of the ALPL gene encoding the enzyme tissue non-specific alkaline phosphatase (TNSALP). HPP is characterized by low serum TNSALP concentrations associated with defective bone mineralization and increased fracture risk. Dental manifestations have been reported as the exclusive feature (odontohypophosphatasia) and in combination with skeletal complications. Enzyme replacement therapy (asfotase alfa) has been shown to improve respiratory insufficiency and skeletal complications in HPP patients, while its effects on dental status have been understudied to date. In this study, quantitative backscattered electron imaging (qBEI) and histological analysis were performed on teeth from two patients with infantile HPP before and during asfotase alfa treatment and compared to matched healthy control teeth. qBEI and histological methods revealed varying mineralization patterns in cementum and dentin with lower mineralization in HPP. Furthermore, a significantly higher repair cementum thickness was observed in HPP compared to control teeth. Comparison before and during treatment showed minor improvements in mineralization and histological parameters in the patient when normalized to matched control teeth. HPP induces heterogeneous effects on mineralization and morphology of the dental status. Short treatment with asfotase alfa slightly affects mineralization in cementum and dentin. Despite HPP being a rare disease, its mild form occurs at higher prevalence. This study is of high clinical relevance as it expands our knowledge of HPP and dental involvement. Furthermore, it contributes to the understanding of dental tissue treatment, which has hardly been studied so far.
Identifiants
pubmed: 36414794
doi: 10.1007/s00223-022-01041-4
pii: 10.1007/s00223-022-01041-4
pmc: PMC9968273
doi:
Substances chimiques
Alkaline Phosphatase
EC 3.1.3.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
308-319Informations de copyright
© 2022. The Author(s).
Références
Bone. 2019 Apr;121:149-162
pubmed: 30576866
Clin Case Rep. 2020 Mar 13;8(5):911-918
pubmed: 32477544
Lancet Diabetes Endocrinol. 2019 Feb;7(2):93-105
pubmed: 30558909
BMC Med Genet. 2009 Jun 06;10:51
pubmed: 19500388
J Mech Behav Biomed Mater. 2021 Jan;113:104138
pubmed: 33157423
Osteoporos Int. 2020 Sep;31(9):1607-1627
pubmed: 32458029
J Bone Miner Res. 2020 Nov;35(11):2171-2178
pubmed: 32654183
Int J Biol Sci. 2018 Apr 30;14(7):693-704
pubmed: 29910680
Bone. 2019 Oct;127:67-74
pubmed: 31152801
Orphanet J Rare Dis. 2009 Feb 21;4:6
pubmed: 19232125
J Clin Pediatr Dent. 2016;40(6):496-502
pubmed: 27805893
Osteoporos Int. 2019 Sep;30(9):1713-1722
pubmed: 30915507
Clin Pediatr Endocrinol. 2020;29(3):115-118
pubmed: 32694888
Calcif Tissue Int. 2021 Mar;108(3):288-301
pubmed: 33191482
BMC Oral Health. 2016 Aug 17;16(1):70
pubmed: 27531358
Endocr Rev. 1994 Aug;15(4):439-61
pubmed: 7988481
Hum Mutat. 1999;13(2):171-2
pubmed: 10094560
Curr Osteoporos Rep. 2016 Jun;14(3):95-105
pubmed: 27084188
J Clin Endocrinol Metab. 2016 Jan;101(1):334-42
pubmed: 26529632
Arch Pediatr. 2017 May;24(5S2):5S66-5S70
pubmed: 29405935
J Dent Res. 2005 Nov;84(11):1021-5
pubmed: 16246934
Eur J Hum Genet. 2021 Feb;29(2):289-299
pubmed: 32973344
J Dent Res. 2011 Apr;90(4):470-6
pubmed: 21212313
Bone. 2015 Mar;72:137-47
pubmed: 25433339
J Struct Biol. 2020 Oct 1;212(1):107597
pubmed: 32758526
Bone. 2021 Feb;143:115794
pubmed: 33301963
Proc Natl Acad Sci U S A. 1988 Oct;85(20):7666-9
pubmed: 3174660
J Bone Miner Res. 2008 Jun;23(6):777-87
pubmed: 18086009
Endocr Rev. 2014 Feb;35(1):1-34
pubmed: 23939820
Br Dent J. 2018 Jun 22;224(12):937-943
pubmed: 29999027
J Dent Res. 2014 Jul;93(7 Suppl):7S-19S
pubmed: 24700690
J Endod. 2012 Jul;38(7):907-12
pubmed: 22703652
J Oral Pathol Med. 1996 Jul;25(6):343-7
pubmed: 8887081
Bone. 2021 Feb;143:115732
pubmed: 33160095
J Bone Miner Res. 2016 Nov;31(11):2041-2047
pubmed: 27192388
Drug Des Devel Ther. 2018 Sep 24;12:3147-3161
pubmed: 30288020
J Bone Miner Res. 2013 Feb;28(2):271-82
pubmed: 22991301
J Bone Miner Res. 2012 Aug;27(8):1722-34
pubmed: 22461224
Bone. 2013 May;54(1):21-7
pubmed: 23352924
Arch Pediatr. 2017 May;24(5S2):5S80-5S84
pubmed: 29405938
J Clin Endocrinol Metab. 2008 Sep;93(9):3443-8
pubmed: 18559907
Eur J Pediatr. 2013 Jun;172(6):851-3
pubmed: 23093139